Prognostic factors and outcomes of adult-onset hemophagocytic lymphohistiocytosis: A retrospective analysis of 34 cases

Hematology Reports

Volumn 7, Issue 2, 2015, Pages 48-51

  Oto, Masafumi ^a   Yoshitsugu, Kanako ^a   Uneda, Shima ^a   Nagamine, Michiko ^a   Yoshida, Minoru ^a  

^a JAPANESE RED CROSS KUMAMOTO HOSPITAL   (Japan)

Author keywords

Adult; Autopsy; Hemophagocytic lymphohistiocytosis; Prognosis

Indexed keywords

BLEOMYCIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; RITUXIMAB; STEROID; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; ERYTHROPHAGOCYTOSIS; FEMALE; GENE MUTATION; HEMOPHAGOCYTIC SYNDROME; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; JAPANESE (PEOPLE); KIKUCHI DISEASE; LYMPHOMA; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; VERY ELDERLY;

EID: 84980587180     PISSN: 20388322     EISSN: 20388330     Source Type: Journal    
DOI: 10.4081/hr.2015.5841     Document Type: Article

References (17)

1. Trottestam H, Horne A, Aricò M, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 2011;118:4577.
2. Okamoto M, Yamaguchi H, Isobe Y, et al. Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome. Intern Med 2009;48:775.
3. Fukaya S, Yasuda S, Hashimoto T, et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) 2008;47:1686.
4. Jordan MB, Allen CE, Weitzman S, et al. How I treat hemophagocytic lymphohistiocytosis. Blood 2011;118:4041-52.
5. Göransdotter Ericson K, Fadeel B, Nilsson- Ardnor S, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet 2001;68: 590-7.
6. Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 2007;86: 58-65.
7. Dobke J. Treatment Protocol of the Second International HLH study 2004. Available from: http://www.kinderkrebsinfo.de/health_professionals/clinical_trials/pohkinderkrebsinfotherapiestudien/hlh_2004/index_eng.html
8. Li J, Wang Q, Zheng W, et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine 2014;93: 100-5.
9. Shimada K, Kinoshita T, Naoe T, Nakamura S. Presentation and management of intravascular large B-cell lymphoma. Lancet Oncol 2009;10:895-902.
10. Murase T, Yamaguchi M, Suzuki R, et al. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 2007; 109:478-85.
11. Zhang K, Jordan MB, Marsh RA, et al. Hypomorphic mutations in PRF1, MUNC13- 4, and STXBP2 are associated with adultonset familial HLH. Blood 2011;118:5794-8.
12. Nagafuji K, Nonami A, Kumano T, et al. Perforin gene mutations in adult-onset hemophagocytic lymphohistiocytosis. Haematologica 2007;92:978-81.
13. Ueda I, Kurokawa Y, Koike K, et al. Lateonset cases of familial hemophagocytic lymphohistiocytosis with missense perforin gene mutations. Am J Hematol 2007; 82:427-32.
14. Tsuji T, Yamasaki H, Arima N, Tsuda H. Hemophagocytic lymphohistiocytosis associated with myelodysplastic syndromes. Int J Hematol 2010;92:547-9.
15. Imashuku S, Kitazawa K, Ishii M, et al. Bone marrow changes mimicking myelodysplasia in patients with hemophagocytic lymphohistiocytosis. Int J Hematol 2000;72:353-7.
16. Lin TF, Ferlic-Stark LL, Allen CE, et al. Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Pediatr Blood Cancer 2011;56:154-5.
17. Parikh SA, Kapoor P, Letendre L, et al. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc 2014;89:484-92.